Table 1.
Characteristic | Participants (n=424) |
---|---|
Mean age, years (SD) | 49 (17) |
Female | 199 (47%) |
Race | |
White | 358 (84%) |
Black | 32 (8%) |
Asian | 17 (4%) |
Other | 16 (4%) |
Hispanic/Latinx ethnicity | 25 (6%) |
Mean body mass index, kg/m2 (SD) | 30 (8) |
Medical history | |
Depression | 115 (27%) |
Anxiety | 127 (30%) |
Mood disorder (other) | 15 (4%) |
Chronic pain condition | 158 (37%) |
Prior ureteroscopy | 154 (36%) |
Prior ureteral stent placement | 170 (40%) |
Severe pain with prior ureteral stent | 80 (19%) |
Severe urinary symptoms with prior ureteral stent | 102 (24%) |
Medication use in 30 days prior to URS | |
Opioids | 111 (26%) |
NSAIDs | 155 (37%) |
Tamsulosin (or alpha blocker) | 136 (32%) |
Oxybutynin (or anticholinergic) | 9 (2.1%) |
Data shown are n (%) except where indicated. SD = standard deviation; NSAIDs = nonsteroidal anti-inflammatory drugs.